first evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia
Published 9 years ago • 34 plays • Length 5:05Download video MP4
Download video MP3
Similar videos
-
5:41
tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia
-
6:31
first randomised evidence for kinase inhibitor activity in acute myeloid leukaemia
-
6:33
evidence for kinase inhibitor activity in acute myeloid leukaemia
-
6:08
measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia
-
9:08
selecting a tyrosine kinase inhibitor in chronic myeloid leukemia case study
-
4:20
tyrosine kinase inhibitors (tkis) - imatinib (gleevec) - pharmacology - cml and all
-
33:30
bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: context and impact of new data
-
6:45
anti-pd1 or tyrosine kinase inhibitors?
-
1:47
optimal use of tyrosine kinase inhibitors as a treatment for philadelphia chromosome-positive ac...
-
5:04
implications of the ratify trial in acute myeloid leukemia
-
6:52
comparison of btk inhibitors for cll
-
2:03
update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia
-
39:50
flt3 inhibitors in the therapy of acute myeloid leukemia
-
1:36
the challenges of using kinase inhibitors for aml treatment
-
8:41
use of vegf-targeted tyrosine kinase inhibitors
-
20:29
role of flt3 inhibitors and other novel agents in aml
-
2:28
midostaurin: the first drug to receive approval for aml since 2000
-
5:34
second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia
-
34:51
fine-tuning chronic lymphocytic leukemia management: optimising bruton tyrosine kinase inhibitor ...